- 12-Week # shares sold: 5,000
- 24-Week # shares sold: 11,500
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) said today that trials of their cholesterol drug Praulent met targets.
Pfizer's $14 billion acquisition of Medivation is a strong purchase, according to Jim Cramer, who now wonders what Sanofi will do next.
Trade-Ideas LLC identified Regeneron Pharmaceuticals (REGN) as an unusual social activity candidate